Andere talen EDAP TMS S.A.

Aandelen

EDAP

US2683111072

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
6,84 ^USD	-3,53%		-7,07%	+29,55%

19/04	Europese aandelen verhandeld in VS als American Depositary Receipts trend hoger in vrijdaghandel, maar eindigen week lager	MT
04/04	Europese aandelen verhandeld in VS als American Depositary Receipts trend hoger in donderdaghandel	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting	23/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading	04/04
European Equities Traded in the US as American Depositary Receipts Start Week Modestly Higher	01/04
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading	27/03
EDAP TMS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results	27/03
EDAP TMS S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/03
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading	26/03
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024	13/03
EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024	13/03
EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference	06/03
EDAP TMS S A : Focal One HIFU has potential to address large market impacting thousands of women each year - Form 6-K	04/03
EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis	04/03
EDAP TMS SA Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis	04/03
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat	01/03
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	29/02
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues	29/02
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues	29/02
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading	27/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen EDAP TMS S.A.

Aandelen

EDAP

US2683111072

Andere talen

Filters